Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis

Annals of Surgical Oncology

Volumn 20, Issue 4, 2013, Pages 1329-1335

  Lang, Brian Hung Hin ^a   Wong, Kai Pun ^a   Cheung, Chung Yeung ^a   Wan, Koon Yat ^a   Lo, Chung Yau ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; BONE METASTASIS; BRAIN METASTASIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIFFERENTIATED THYROID CANCER; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROPORTIONAL HAZARDS MODEL; SCHOOL CHILD; SKIN METASTASIS; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CARCINOMA, PAPILLARY; CATHETER ABLATION; CHILD; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY; YOUNG ADULT;

EID: 84875149129     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2711-x     Document Type: Conference Paper

References (22)

1. DS Cooper GM Doherty BR Hauger, et al. 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid. 19 1167 1214 19860577 10.1089/thy.2009.0110
2. BH Lang CY Lo WF Chan KY Lam KY Wan 2007 Staging systems for papillary thyroid carcinoma: a review and comparison Ann Surg. 245 366 378 17435543 10.1097/01.sla.0000250445.92336.2a
3. BH Lang CY Lo WF Chan KY Lam KY Wan 2007 Prognostic factors in papillary and follicular thyroid carcinoma: implications for cancer staging Ann Surg Oncol. 14 730 738 17103065 10.1245/s10434-006-9207-5
4. J Lee EY Soh 2010 Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors Ann Surg. 251 114 119 19779325 10.1097/SLA.0b013e3181b7faf6
5. SF Dinneen MJ Valimaki EJ Bergstralh JR Goellner CA Gorman ID Hay 1995 Distant metastases in papillary thyroid carcinoma:100 cases observed at one institution during 5 decades J Clin Endocrinol Metab. 80 2041 2045 7608252 10.1210/jc.80.7.2041 1:CAS:528:DyaK2MXmvVyqt78%3D
6. C Durante N Haddy E Baudin, et al. 2006 Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy J Clin Endocrinol Metab. 91 2892 2899 16684830 10.1210/jc.2005-2838 1:CAS:528:DC%2BD28XosFGhs70%3D
7. JD Lin MJ Huang JH Juang, et al. 1999 Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases Thyroid. 9 1227 1235 10646663 10.1089/thy.1999.9.1227 1:STN:280: DC%2BD3c7htVGrsQ%3D%3D
8. M Haq C Harmer 2005 Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome Clin Endocrinol (Oxf). 63 87 93 10.1111/j.1365-2265.2005.02304.x 1:STN:280: DC%2BD2MzhsFCiug%3D%3D
9. E Sampson JD Brierley LW Le L Rotstein RW Tsang 2007 Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis Cancer. 110 1451 1456 17705176 10.1002/cncr.22956
10. J Mihailovic L Stefanovic M Malesevic B Markoski 2009 The importance of age over radioiodine avidity as a prognostic factor in differentiated thyroid carcinoma with distant metastases Thyroid. 19 227 232 19265493 10.1089/thy.2008.0186 1:CAS:528:DC%2BD1MXivVGktLk%3D
11. IJ Nixon MM Whitcher FL Palmer, et al. 2012 The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland Thyroid. 22 884 889 22827579 10.1089/thy.2011. 0535
12. M Shoup A Stojadinovic A Nissan, et al. 2003 Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma J Am Coll Surg. 197 191 197 12892796 10.1016/S1072-7515(03)00332-6
13. IC Huang FF Chou RT Liu, et al. 2012 Long-term outcomes of distant metastasis from differentiated thyroid carcinoma Clin Endocrinol (Oxf). 76 439 447 10.1111/j.1365-2265.2011.04231.x 1:CAS:528:DC%2BC38XjvFOltL8%3D
14. I Sugitani Y Fujimoto N Yamamoto 2008 Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control Surgery. 143 35 42 18154931 10.1016/j.surg.2007.06.011
15. SM Chow S Yau CK Kwan PC Poon SC Law 2006 Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition Endocr Relat Cancer. 13 1159 1172 17158761 10.1677/erc.1.01320
16. H Wong KP Wong T Yau, et al. 2012 Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation? Ann Surg Oncol. 19 3479 3485 22576067 10.1245/s10434-012-2391-6
17. Y Orita I Sugitani M Matsuura, et al. 2010 Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma Surgery. 147 424 431 20176243 10.1016/j.surg.2009.10.009
18. BR Haugen MA Kane 2010 Approach to the thyroid cancer patient with extracervical metastases J Clin Endocrinol Metab. 95 987 993 20203334 10.1210/jc.2009-2305 1:CAS:528:DC%2BC3cXjs1KqsL0%3D
19. BH Lang TT Law 2011 The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms Oncologist. 16 458 466 21378078 10.1634/theoncologist.2010-0256 1:CAS:528:DC%2BC3MXhtlSktrvO
20. 18F]fluoro-2-deoxy-d-glucose-positron emission tomography scanning J Clin Endocrinol Metab. 91 498 505 16303836 10.1210/jc.2005-1534 1:CAS:528:DC%2BD28XhsFKntb0%3D
21. WG Kim JS Ryu EY Kim, et al. 2010 Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan J Clin Endocrinol Metab. 95 1169 1173 20080852 10.1210/jc.2009-1567 1:CAS:528:DC%2BC3cXjs1Kqtrs%3D
22. G Vitale F Fonderico A Martignetti, et al. 2001 Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer Br J Cancer. 84 1586 1590 11401309 10.1054/bjoc.2001.1832 1:CAS:528:DC%2BD3MXlt1Oht7o%3D